$ZTS
Zoetis Inc.

2016 Q2 Form 10-Q Financial Statement

#000155528016000387 Filed on May 06, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q1
Revenue $1.162B $1.102B
YoY Change -1.11% 0.46%
Cost Of Revenue $389.0M $394.0M
YoY Change -8.9% 3.96%
Gross Profit $773.0M $708.0M
YoY Change 3.34% -1.39%
Gross Profit Margin 66.52% 64.25%
Selling, General & Admin $315.0M $354.0M
YoY Change -16.89% -0.56%
% of Gross Profit 40.75% 50.0%
Research & Development $90.00M $80.00M
YoY Change 7.14% -8.05%
% of Gross Profit 11.64% 11.3%
Depreciation & Amortization $57.00M $48.00M
YoY Change 14.0% -4.0%
% of Gross Profit 7.37% 6.78%
Operating Expenses $405.0M $434.0M
YoY Change -12.53% -2.03%
Operating Profit $368.0M $274.0M
YoY Change 29.12% -0.36%
Interest Expense $43.00M $28.00M
YoY Change 48.28% -3.45%
% of Operating Profit 11.68% 10.22%
Other Income/Expense, Net $30.00M $0.00
YoY Change -1600.0% -100.0%
Pretax Income $332.0M $230.0M
YoY Change -1329.63% 1.32%
Income Tax $128.0M $65.00M
% Of Pretax Income 38.55% 28.26%
Net Earnings $204.0M $165.0M
YoY Change -651.35% 6.45%
Net Earnings / Revenue 17.56% 14.97%
Basic Earnings Per Share $0.41 $0.33
Diluted Earnings Per Share $0.41 $0.33
COMMON SHARES
Basic Shares Outstanding 497.4M shares 501.1M shares
Diluted Shares Outstanding 499.5M shares 503.2M shares

Balance Sheet

Concept 2016 Q2 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $675.0M $559.0M
YoY Change 24.08% 10.47%
Cash & Equivalents $675.0M $559.0M
Short-Term Investments
Other Short-Term Assets $236.0M $213.0M
YoY Change 0.43% 3.9%
Inventory $1.461B $1.346B
Prepaid Expenses
Receivables $908.0M $905.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.307B $3.110B
YoY Change -0.27% -3.48%
LONG-TERM ASSETS
Property, Plant & Equipment $1.317B $1.301B
YoY Change 1.7% 0.7%
Goodwill $1.459B $1.169B
YoY Change 25.02% 19.04%
Intangibles $1.210B $735.0M
YoY Change 73.6% -6.61%
Long-Term Investments
YoY Change
Other Assets $48.00M $58.00M
YoY Change -17.24% -7.94%
Total Long-Term Assets $4.146B $3.320B
YoY Change 26.33% 4.37%
TOTAL ASSETS
Total Short-Term Assets $3.307B $3.110B
Total Long-Term Assets $4.146B $3.320B
Total Assets $7.453B $6.430B
YoY Change 12.96% 0.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $210.0M $256.0M
YoY Change -24.46% -29.48%
Accrued Expenses $718.0M $599.0M
YoY Change -9.34% 238.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $400.0M
YoY Change -100.0% 2400.0%
Total Short-Term Liabilities $1.163B $1.370B
YoY Change -26.02% 21.56%
LONG-TERM LIABILITIES
Long-Term Debt $4.464B $3.243B
YoY Change 37.65% -10.96%
Other Long-Term Liabilities $246.0M $199.0M
YoY Change -14.58% 20.61%
Total Long-Term Liabilities $4.710B $3.442B
YoY Change 33.39% -9.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.163B $1.370B
Total Long-Term Liabilities $4.710B $3.442B
Total Liabilities $6.266B $5.125B
YoY Change 16.12% -3.37%
SHAREHOLDERS EQUITY
Retained Earnings $1.016B $832.0M
YoY Change 27.8% 110.63%
Common Stock $5.000M $5.000M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $245.0M $49.00M
YoY Change 145.0%
Treasury Stock Shares 5.475M shares 1.087M shares
Shareholders Equity $1.165B $1.278B
YoY Change
Total Liabilities & Shareholders Equity $7.453B $6.430B
YoY Change 12.96% 0.42%

Cashflow Statement

Concept 2016 Q2 2015 Q1
OPERATING ACTIVITIES
Net Income $204.0M $165.0M
YoY Change -651.35% 6.45%
Depreciation, Depletion And Amortization $57.00M $48.00M
YoY Change 14.0% -4.0%
Cash From Operating Activities $51.00M $60.00M
YoY Change -58.2% -360.87%
INVESTING ACTIVITIES
Capital Expenditures $45.00M $45.00M
YoY Change -116.36% 0.0%
Acquisitions $12.00M $230.0M
YoY Change
Other Investing Activities $0.00 -$229.0M
YoY Change -100.0%
Cash From Investing Activities $18.00M -$274.0M
YoY Change -140.91% 508.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $76.00M $48.00M
YoY Change
Debt Paid & Issued, Net $400.0M $0.00
YoY Change
Cash From Financing Activities -$543.0M -$94.00M
YoY Change 496.7% 168.57%
NET CHANGE
Cash From Operating Activities $51.00M $60.00M
Cash From Investing Activities $18.00M -$274.0M
Cash From Financing Activities -$543.0M -$94.00M
Net Change In Cash -$474.0M -$308.0M
YoY Change 3546.15% 199.03%
FREE CASH FLOW
Cash From Operating Activities $51.00M $60.00M
Capital Expenditures $45.00M $45.00M
Free Cash Flow $6.000M $15.00M
YoY Change -98.49% -122.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1007000000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1012000000 USD
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
908000000 USD
CY2015Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
63000000 USD
CY2016Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
123000000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1208000000 USD
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1248000000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-622000000 USD
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-618000000 USD
CY2016Q2 dei Amendment Flag
AmendmentFlag
false
CY2016Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016Q2 dei Document Period End Date
DocumentPeriodEndDate
2016-04-03
CY2016Q2 dei Document Type
DocumentType
10-Q
CY2016Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001555280
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
496202370 shares
CY2016Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q2 dei Entity Registrant Name
EntityRegistrantName
Zoetis Inc.
CY2016Q2 dei Trading Symbol
TradingSymbol
ZTS
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
293000000 USD
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
210000000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
937000000 USD
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8000000 USD
CY2016Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000000 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34000000 USD
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32000000 USD
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15000000 USD
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24000000 USD
CY2015Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1000000 USD
CY2016Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2015Q4 us-gaap Assets
Assets
7913000000 USD
CY2016Q2 us-gaap Assets
Assets
7453000000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
3830000000 USD
CY2016Q2 us-gaap Assets Current
AssetsCurrent
3307000000 USD
CY2015Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
71000000 USD
CY2016Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
27000000 USD
CY2015Q4 us-gaap Business Combination Acquired Receivables Estimated Uncollectible
BusinessCombinationAcquiredReceivablesEstimatedUncollectible
1000000 USD
CY2015Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
10000000 USD
CY2016Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9000000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
882000000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
559000000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1154000000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
675000000 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-323000000 USD
CY2016Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-479000000 USD
CY2015Q4 us-gaap Commercial Paper
CommercialPaper
0 USD
CY2016Q2 us-gaap Commercial Paper
CommercialPaper
0 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.083
CY2016Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.095
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
501340000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
501460000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
501810000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
501808229 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
501891835 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
501890000 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
500367604 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
497400113 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
496416809 shares
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
5000000 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
5000000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47000000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
208000000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000000 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
48000000 USD
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
207000000 USD
CY2015Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
394000000 USD
CY2016Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
389000000 USD
CY2015Q4 us-gaap Debt Current
DebtCurrent
5000000 USD
CY2016Q2 us-gaap Debt Current
DebtCurrent
4000000 USD
CY2015Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4900000000 USD
CY2016Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4500000000 USD
CY2015Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-37000000 USD
CY2016Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-36000000 USD
CY2015Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3000000 USD
CY2016Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-25000000 USD
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
82000000 USD
CY2016Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
112000000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
182000000 USD
CY2016Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
158000000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
264000000 USD
CY2016Q2 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
270000000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
264000000 USD
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
270000000 USD
CY2015Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
2000000 USD
CY2016Q2 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
3000000 USD
CY2015Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
0 USD
CY2016Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1000000 USD
CY2015Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1000000 USD
CY2016Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1000000 USD
CY2015Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
3000000 USD
CY2016Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
2000000 USD
CY2015Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2000000 USD
CY2016Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2000000 USD
CY2016Q2 us-gaap Defined Benefit Plans Estimated Future Employer Contributions In Current Fiscal Year
DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear
8000000 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48000000 USD
CY2016Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
57000000 USD
CY2015Q1 us-gaap Dividends Common Stock
DividendsCommonStock
42000000 USD
CY2016Q2 us-gaap Dividends Common Stock
DividendsCommonStock
49000000 USD
CY2015Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
47000000 USD
CY2016Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
49000000 USD
CY2015Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
42000000 USD
CY2016Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
49000000 USD
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-15000000 USD
CY2016Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5000000 USD
CY2015Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.283
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.386
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
234000000 USD
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
166000000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
557000000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
580000000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1499000000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1541000000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
942000000 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
961000000 USD
CY2015Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8000000 USD
CY2016Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9000000 USD
CY2015Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2016Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
33000000 USD
CY2015Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
CY2016Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
33000000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
1455000000 USD
CY2016Q2 us-gaap Goodwill
Goodwill
1459000000 USD
CY2016Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
2000000 USD
CY2015Q4 us-gaap Goodwill Gross
GoodwillGross
1991000000 USD
CY2016Q2 us-gaap Goodwill Gross
GoodwillGross
1995000000 USD
CY2016Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
536000000 USD
CY2016Q2 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
6000000 USD
CY2016Q2 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
13000000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
230000000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
332000000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65000000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
128000000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
9000000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
10000000 USD
CY2015Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
52000000 USD
CY2016Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
49000000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-26000000 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-84000000 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4000000 USD
CY2016Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21000000 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
11000000 USD
CY2016Q2 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
114000000 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
77000000 USD
CY2016Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3000000 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5000000 USD
CY2016Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
36000000 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-82000000 USD
CY2016Q2 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-193000000 USD
CY2015Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
248000000 USD
CY2016Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
249000000 USD
CY2015Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1747000000 USD
CY2016Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1790000000 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1190000000 USD
CY2016Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1210000000 USD
CY2015Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1000000 USD
CY2016Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1000000 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
28000000 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
43000000 USD
CY2015Q1 us-gaap Interest Paid Net
InterestPaidNet
58000000 USD
CY2016Q2 us-gaap Interest Paid Net
InterestPaidNet
58000000 USD
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
758000000 USD
CY2016Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
765000000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
1467000000 USD
CY2016Q2 us-gaap Inventory Net
InventoryNet
1461000000 USD
CY2015Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
325000000 USD
CY2016Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
214000000 USD
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
384000000 USD
CY2016Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
482000000 USD
CY2015Q1 us-gaap Inventory Write Down
InventoryWriteDown
18000000 USD
CY2016Q2 us-gaap Inventory Write Down
InventoryWriteDown
16000000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
6822000000 USD
CY2016Q2 us-gaap Liabilities
Liabilities
6266000000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7913000000 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7453000000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1781000000 USD
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1163000000 USD
CY2015Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2016Q2 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2016Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
91000000 USD
CY2015Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
13000000 USD
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
400000000 USD
CY2016Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
500000000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
750000000 USD
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4463000000 USD
CY2016Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4464000000 USD
CY2013Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
11000000 EUR
CY2013Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
14000000 USD
CY2015Q2 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
1 category
CY2015Q4 us-gaap Minority Interest
MinorityInterest
23000000 USD
CY2016Q2 us-gaap Minority Interest
MinorityInterest
22000000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-94000000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-543000000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-274000000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18000000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
60000000 USD
CY2016Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
51000000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
165000000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
204000000 USD
CY2015Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
30000000 USD
CY2016Q2 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
45 country
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-118000000 USD
CY2016Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2015Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
676000000 USD
CY2016Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
552000000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2000000 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-117000000 USD
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000000 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
59000000 USD
CY2016Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
60000000 USD
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
201000000 USD
CY2016Q2 us-gaap Other Assets Current
OtherAssetsCurrent
236000000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49000000 USD
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
48000000 USD
CY2015Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
1000000 USD
CY2016Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
1000000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
251000000 USD
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
246000000 USD
CY2015Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
400000000 USD
CY2016Q2 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
0 USD
CY2015Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3000000 USD
CY2016Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000000 USD
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 USD
CY2015Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
4000000 USD
CY2016Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
4000000 USD
CY2015Q1 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
22000000 USD
CY2016Q2 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
27000000 USD
CY2015Q1 us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
0 USD
CY2016Q2 us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
22000000 USD
CY2015Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
48000000 USD
CY2016Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
76000000 USD
CY2015Q1 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
42000000 USD
CY2016Q2 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
47000000 USD
CY2015Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
230000000 USD
CY2016Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12000000 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45000000 USD
CY2016Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45000000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000000 shares
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2016Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2015Q1 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
1000000 USD
CY2016Q2 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
3000000 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
1165000000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1337000000 USD
CY2016Q2 us-gaap Restructuring Charges
RestructuringCharges
2000000 USD
CY2015Q4 us-gaap Restructuring Reserve
RestructuringReserve
222000000 USD
CY2016Q2 us-gaap Restructuring Reserve
RestructuringReserve
186000000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
876000000 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1016000000 USD
CY2015Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-5000000 USD
CY2016Q2 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-1000000 USD
CY2015Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000000 USD
CY2016Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
75000000 USD
CY2015Q1 us-gaap Profit Loss
ProfitLoss
165000000 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
204000000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1307000000 USD
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1317000000 USD
CY2015Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2016Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
400000000 USD
CY2015Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
80000000 USD
CY2016Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
90000000 USD
CY2016Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
1400
CY2015Q1 us-gaap Royalty Revenue
RoyaltyRevenue
7000000 USD
CY2016Q2 us-gaap Royalty Revenue
RoyaltyRevenue
7000000 USD
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
1102000000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1162000000 USD
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
354000000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
315000000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
10000000 USD
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
9000000 USD
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0090
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2685
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0156
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
877608 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.19
CY2016Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
41.83
CY2016Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
CY2015Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
5000000 USD
CY2016Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
4000000 USD
CY2015Q4 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.052
CY2016Q2 us-gaap Short Term Debt Weighted Average Interest Rate
ShortTermDebtWeightedAverageInterestRate
0.054
CY2015Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
110000 shares
CY2016Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
80000 shares
CY2014Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
500000000 USD
CY2016Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
225000000 USD
CY2015Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2016Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
1068000000 USD
CY2015Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1305000000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1091000000 USD
CY2016Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1187000000 USD
CY2015Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
63000000 USD
CY2016Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
118000000 USD
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
20000 shares
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1090000 shares
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1087313 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4408116 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4410000 shares
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
5480000 shares
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
5475026 shares
CY2015Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
20000 shares
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
203000000 USD
CY2016Q2 us-gaap Treasury Stock Value
TreasuryStockValue
245000000 USD
CY2015Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
47000000 USD
CY2016Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
76000000 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
61000000 USD
CY2016Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
120000000 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
7000000 USD
CY2016Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
8000000 USD
CY2016Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
35000000 USD
CY2015Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2100000 shares
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2100000 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
503200000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
499500000 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
501100000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
497400000 shares
CY2015Q1 zts Allocated Share Based Compensation Expense Direct And Indirect Expense
AllocatedShareBasedCompensationExpenseDirectAndIndirectExpense
10000000 USD
CY2016Q2 zts Allocated Share Based Compensation Expense Direct And Indirect Expense
AllocatedShareBasedCompensationExpenseDirectAndIndirectExpense
9000000 USD
CY2015Q1 zts Amortization Of Intangible Assets Not Associated With Single Function
AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction
15000000 USD
CY2016Q2 zts Amortization Of Intangible Assets Not Associated With Single Function
AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction
21000000 USD
CY2015Q1 zts Contributed Capital Associatedwith Pension To Be Contributedby Related Party
ContributedCapitalAssociatedwithPensionToBeContributedbyRelatedParty
1000000 USD
CY2016Q2 zts Contributed Capital Associatedwith Pension To Be Contributedby Related Party
ContributedCapitalAssociatedwithPensionToBeContributedbyRelatedParty
1000000 USD
CY2015Q1 zts Cost Reduction Initiatives And Acquisition Costs
CostReductionInitiativesAndAcquisitionCosts
16000000 USD
CY2016Q2 zts Cost Reduction Initiatives And Acquisition Costs
CostReductionInitiativesAndAcquisitionCosts
-25000000 USD
CY2016Q2 zts Excess Tax Benefits
ExcessTaxBenefits
4000000 USD
CY2015Q1 zts Investor Related Costs
InvestorRelatedCosts
3000000 USD
CY2015Q4 zts Liabilities Heldforsale Not Partof Disposal Group Current
LiabilitiesHeldforsaleNotPartofDisposalGroupCurrent
4000000 USD
CY2016Q2 zts Liabilities Heldforsale Not Partof Disposal Group Current
LiabilitiesHeldforsaleNotPartofDisposalGroupCurrent
4000000 USD
CY2016Q2 zts Line Of Credit Facility Covenant Compliance Minimum Interest Coverage Ratio
LineOfCreditFacilityCovenantComplianceMinimumInterestCoverageRatio
3.50
CY2016Q2 zts Long Term Debt Maturities Repayments Of Principal After Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearSix
3250000000 USD
CY2016Q2 zts Long Term Debt Maturities Repayments Of Principal In Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix
0 USD
CY2016Q2 zts Manufacturing Sites Heldfor Sale Expected Period
ManufacturingSitesHeldforSaleExpectedPeriod
P1Y
CY2015Q1 zts Non Cash Transfersto Related Party
NonCashTransferstoRelatedParty
1000000 USD
CY2016Q2 zts Non Cash Transfersto Related Party
NonCashTransferstoRelatedParty
1000000 USD
CY2016Q2 zts Number Of Core Animal Species Marketed
NumberOfCoreAnimalSpeciesMarketed
8 species
CY2016Q2 zts Number Of Major Product Categories
NumberOfMajorProductCategories
5 category
CY2015Q2 zts Number Of Major Product Categories
NumberOfMajorProductCategories
5000 product
CY2014Q3 zts Numberof Contaminated Contaminationof Animal Feed
NumberofContaminatedContaminationofAnimalFeed
20000 animal
CY2014Q3 zts Numberof Deaths Contaminationof Animal Feed
NumberofDeathsContaminationofAnimalFeed
50000 animal
CY2016Q2 zts Numberof Regional Segments
NumberofRegionalSegments
2 region
CY2015Q1 zts Operational Efficiency Consulting Charges
OperationalEfficiencyConsultingCharges
10000000 USD
CY2016Q2 zts Operational Efficiency Consulting Charges
OperationalEfficiencyConsultingCharges
3000000 USD
CY2015Q1 zts Restructuring And Other Related Costs Net Of Payments
RestructuringAndOtherRelatedCostsNetOfPayments
0 USD
CY2016Q2 zts Restructuring And Other Related Costs Net Of Payments
RestructuringAndOtherRelatedCostsNetOfPayments
2000000 USD
CY2015Q1 zts Restructuring Charges And Acquisition Related Costs
RestructuringChargesAndAcquisitionRelatedCosts
1000000 USD
CY2016Q2 zts Restructuring Charges And Acquisition Related Costs
RestructuringChargesAndAcquisitionRelatedCosts
2000000 USD
CY2016Q2 zts Restructuring Reserve Utilization And Other
RestructuringReserveUtilizationAndOther
38000000 USD
CY2016Q2 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Zoetis Inc. (including its subsidiaries, collectively, Zoetis, the company, we, us or our) is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. We organize and operate our business in </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:9pt;"> geographic regions: the United States (U.S.) and International. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">We directly market our products in approximately </font><font style="font-family:inherit;font-size:9pt;">45</font><font style="font-family:inherit;font-size:9pt;"> countries across North America, Europe, Africa, Asia, Australia and South America. Our products are sold in more than </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">100</font><font style="font-family:inherit;font-size:9pt;"> countries, including developed markets and emerging markets. We have a diversified business, marketing products across </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">eight</font><font style="font-family:inherit;font-size:9pt;"> core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals); and within </font><font style="font-family:inherit;font-size:9pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:9pt;"> major product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.</font></div></div>

Files In Submission

Name View Source Status
0001555280-16-000387-index-headers.html Edgar Link pending
0001555280-16-000387-index.html Edgar Link pending
0001555280-16-000387.txt Edgar Link pending
0001555280-16-000387-xbrl.zip Edgar Link pending
a2016q110-qex12.htm Edgar Link pending
a2016q110qex15.htm Edgar Link pending
a2016q110qex311.htm Edgar Link pending
a2016q110qex312.htm Edgar Link pending
a2016q110qex322.htm Edgar Link pending
a2016q1form10-q.htm Edgar Link pending
a216q110qex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zts-20160327.xml Edgar Link completed
zts-20160327.xsd Edgar Link pending
zts-20160327_cal.xml Edgar Link unprocessable
zts-20160327_def.xml Edgar Link unprocessable
zts-20160327_lab.xml Edgar Link unprocessable
zts-20160327_pre.xml Edgar Link unprocessable